| 000 | 01886 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513072002.0 | ||
| 264 | 0 | _c19940314 | |
| 008 | 199403s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19940201)73:3+<864::aid-cncr2820731318>3.0.co;2-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharkey, R M | |
| 245 | 0 | 0 |
_aPhase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas. _h[electronic resource] |
| 260 |
_bCancer _cFeb 1994 |
||
| 300 |
_a864-77 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xmetabolism |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xtherapy |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _ximmunology |
| 650 | 0 | 4 |
_aImmunoglobulin G _ximmunology |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMice _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRadioimmunotherapy |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aGoldenberg, D M | |
| 700 | 1 | _aVagg, R | |
| 700 | 1 | _aPawlyk, D | |
| 700 | 1 | _aWong, G Y | |
| 700 | 1 | _aSiegel, J A | |
| 700 | 1 | _aMurthy, S | |
| 700 | 1 | _aLevine, G M | |
| 700 | 1 | _aIzon, D | |
| 700 | 1 | _aGascon, P | |
| 773 | 0 |
_tCancer _gvol. 73 _gno. 3 Suppl _gp. 864-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19940201)73:3+<864::aid-cncr2820731318>3.0.co;2-9 _zAvailable from publisher's website |
| 999 |
_c8305553 _d8305553 |
||